Emerging Biomarkers for Early Detection and Prognosis of Bile Duct Cancer
One of the key aspects of precision medicine in bile duct cancer is the identification of genetic mutations and alterations that drive tumor growth. Advances in genomic sequencing technologies have made it possible to identify specific mutations in the DNA of cancer cells with great precision. For example, mutations in genes such as IDH1, IDH2, FGFR2, and BRAF have been found in subsets of bile...
0 Comments 0 Shares 1086 Views 0 Reviews
Sponsored